The role of 18 F-FDG-PET/CT in the management of differentiated thyroid cancer

UOBScholar Hub

Please use this identifier to cite or link to this item: https://scholarhub.balamand.edu.lb/handle/uob/7095

Title:	The role of 18 F-FDG-PET/CT in the management of differentiated thyroid cancer
Authors:	Haidar, Mohamad Kassas, Mutaz Chehade, Feras Chahinian, Rita Abi-Ghosn, Jean Haddad, Marwan M
Affiliations:	Faculty of Medicine
Keywords:	18 F-FDG PET/CT Differentiated thyroid cancer Radioactive iodine Thyroglobulin Whole body scan
Issue Date:	2023-11-01
Publisher:	National Library of Medicine
Part of:	Nuclear Medicine Communications
Volume:	44
Issue:	11
Start page:	1046
End page:	1052
Abstract:	In previous literature, 18 F-FDG-PET/ CT imaging significantly impacted differentiated thyroid cancer (DTC) therapy. Low thyroglobulin (Tg) levels and negative Iodine-131 (131I) whole-body scan (WBS), along with negative 18 F-FDG-PET/ CT, suggested a lesser likelihood of active illness. Positive 18 F-FDG-PET/CT findings, however, were associated with a variety of signs of local recurrence and regional or distant metastases in patients with suspected WBS. We aim to evaluate the utility of 18 F-FDG-PET/CT in managing DTC patients with negative 131I post-therapy WBS and elevated Tg.
URI:	https://scholarhub.balamand.edu.lb/handle/uob/7095
ISSN:	01433636
DOI:	10.1097/MNM.0000000000001758
Open URL:	Link to full text
Type:	Journal Article
Appears in Collections:	Faculty of Medicine

1

checked on May 4, 2024

17

checked on May 6, 2024

Check